CHARM Therapeutics Appoints Dr. Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development
Position
Chief Development Officer
Company
CHARM Therapeutics
LondonBiotechnologyHealthcareHealth CareDescription
CHARM Therapeutics appoints Dr. Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development.
Quick answer
CHARM Therapeutics Appoints Dr. Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development (April 30, 2024). CHARM Therapeutics is based in London, England, United Kingdom.
- Who is the new Chief Development Officer at CHARM Therapeutics?
- CHARM Therapeutics named Nicholas Edmunds Chief Development Officer, announced April 30, 2024.
- What did CHARM Therapeutics announce on April 30, 2024?
- CHARM Therapeutics appoints Dr. Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development.
- What does CHARM Therapeutics do?
- CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold.
- Where is CHARM Therapeutics based?
- CHARM Therapeutics is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Journey Medical Corporation (May 1, 2024), Lykos Therapeutics (May 3, 2024), Interwell Health (April 23, 2024) and Otolith Labs (May 7, 2024) also announced leadership changes within 45 days of CHARM Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Journey Medical Corporation Appoints Joseph M. Benesch as Chief Financial Officer (May 1, 2024)
- Lykos Therapeutics Appoints Allison Rosenthal as Chief Commercial Officer and Coy Stout as Vice President of Market Access (May 3, 2024)
- Interwell Health Appoints Clark Curtis as Chief People Officer (April 23, 2024)
- Otolith Labs Appoints Kevin Franck as Chief Clinical Officer (May 7, 2024)
- Wave Life Sciences Ltd. Appoints Erik Ingelsson, MD, PhD, as Chief Scientific Officer (May 9, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
Who to call at CHARM Therapeutics, and when
A new leader at CHARM Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CHARM Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CHARM Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CHARM Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CHARM Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CHARM Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.